Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 13/20 | 0.49 |
| ▸ | RARA | P10276 | 11/20 | 0.49 |
| ▸ | RARG | P13631 | 11/20 | 0.49 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.41 |
| ▸ | CYP26B1 | Q9NR63 | 3/20 | 0.41 |
| ▸ | RXRA | P19793 | 5/20 | 0.36 |
| ▸ | RXRB | P28702 | 2/20 | 0.36 |
| ▸ | RXRG | P48443 | 2/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4593508 | 0.81 | RXRA (0.44) | RARBRARARARGCYP26A1CYP26B1 | |
| SCHEMBL9054118 | 0.76 | RARB (0.47) | RARBRARARARGCYP26A1CYP26B1 | |
| SCHEMBL8657926 | 0.76 | RARA (0.49) | RARBRARARARGCYP26A1CYP26B1 | |
| SCHEMBL24524497 | 0.76 | RARA (0.49) | RARBRARARARGCYP26A1CYP26B1 | |
| SCHEMBL19230462 | 0.72 | NOS1 (0.41) | — | |
| SCHEMBL9422180 | 0.72 | NOS1 (0.41) | — | |
| SCHEMBL1297632 | 0.72 | NOS1 (0.44) | — | |
| SCHEMBL29644321 | 0.72 | NOS1 (0.44) | — | |
| SCHEMBL8690816 | 0.72 | CA1 (0.50) | RARBRARARARGCYP26A1CYP26B1 | |
| SCHEMBL8900020 | 0.72 | RARB (0.65) | RARBRARARARGCYP26A1CYP26B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | LEF1, L1CAM, PIEZO1 | RARB 2555/4885RARA 1886/4885RARG 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.